PubRank

Emmanuel Roze

Author PubWeight™ 64.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 2009 2.09
2 Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry 2012 1.94
3 Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol 2008 1.91
4 Myoclonus-dystonia: an update. Mov Disord 2009 1.90
5 Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study. Arch Neurol 2011 1.79
6 Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 2007 1.47
7 Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain 2009 1.44
8 Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord 2007 1.42
9 TENS for the treatment of propriospinal myoclonus. Mov Disord 2008 1.41
10 Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem 2009 1.34
11 PRRT2 mutations cause hemiplegic migraine. Neurology 2012 1.30
12 Congenital mirror movements: a clue to understanding bimanual motor control. J Neurol 2011 1.08
13 Defective cerebellar control of cortical plasticity in writer's cramp. Brain 2013 1.06
14 RAD51 deficiency disrupts the corticospinal lateralization of motor control. Brain 2013 1.06
15 Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry 2012 1.05
16 RAD51 haploinsufficiency causes congenital mirror movements in humans. Am J Hum Genet 2012 1.04
17 [123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci 2008 1.04
18 Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression. Orphanet J Rare Dis 2013 1.01
19 Developmental and benign movement disorders in childhood. Mov Disord 2010 1.01
20 Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy. Ann Neurol 2012 1.00
21 PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology 2012 0.99
22 Pathophysiology of dystonia. Curr Opin Neurol 2009 0.96
23 Validation of a new language screening tool for patients with acute stroke: the Language Screening Test (LAST). Stroke 2011 0.96
24 Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype. Neurogenetics 2010 0.94
25 Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008 0.94
26 A motor signature of REM sleep behavior disorder. Mov Disord 2011 0.93
27 Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry 2013 0.93
28 The multiple faces of the ATP1A3-related dystonic movement disorder. Mov Disord 2013 0.91
29 Overall mutational spectrum of SLC20A2, PDGFB and PDGFRB in idiopathic basal ganglia calcification. Neurogenetics 2014 0.91
30 Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet 2011 0.90
31 Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis 2007 0.89
32 Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. Physiol Genomics 2008 0.89
33 Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France. Parkinsonism Relat Disord 2011 0.89
34 The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain 2011 0.88
35 Impaired saccadic adaptation in DYT11 dystonia. J Neurol Neurosurg Psychiatry 2011 0.87
36 Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 2008 0.87
37 Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation. PLoS One 2009 0.86
38 Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency. J Neurol 2010 0.86
39 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis 2014 0.85
40 Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson's disease. Sleep Med 2011 0.84
41 Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. J Neurol 2010 0.84
42 Table tennis dystonia. Mov Disord 2010 0.84
43 Neuromimetic model of saccades for localizing deficits in an atypical eye-movement pathology. J Transl Med 2013 0.83
44 Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep 2010 0.83
45 Myoclonus and dystonia in cerebrotendinous xanthomatosis. Mov Disord 2012 0.81
46 The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. Ann Neurol 2011 0.81
47 REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep 2007 0.81
48 Cortical excitability in DYT-11 positive myoclonus dystonia. Mov Disord 2008 0.81
49 Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood. JIMD Rep 2014 0.81
50 Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain 2010 0.80
51 Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis 2011 0.80
52 Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2. Antioxid Redox Signal 2014 0.80
53 Dopaminergic deficit is not the rule in orthostatic tremor. Mov Disord 2008 0.80
54 Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia. J Neurol 2010 0.79
55 Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion. Am J Med Genet A 2010 0.79
56 Risk factors for spinal cord lesions in dystonic cerebral palsy and generalised dystonia. J Neurol Neurosurg Psychiatry 2011 0.78
57 Simultaneous determination of all forms of biopterin and neopterin in cerebrospinal fluid. ACS Chem Neurosci 2014 0.78
58 Deep brain stimulation for dystonia. Handb Clin Neurol 2013 0.78
59 Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A. Dev Neurorehabil 2009 0.77
60 Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J Mol Neurosci 2011 0.77
61 Generalized dystonia, athetosis, and parkinsonism associated with FOXG1 mutation. Mov Disord 2011 0.77
62 Predominant cortical dysfunction in Guadeloupean parkinsonism. Brain 2008 0.76
63 Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome. Mov Disord 2011 0.76
64 Congenital mirror movements: no mutation in DNAL4 in 17 index cases. J Neurol 2014 0.76
65 Long-standing paraphilia induced by dopamine agonists in Parkinson's disease. Mov Disord 2010 0.76
66 Combined pallidal and subthalamic nucleus deep brain stimulation in secondary dystonia-parkinsonism. Parkinsonism Relat Disord 2013 0.75
67 Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. PLoS One 2016 0.75
68 Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis. Mov Disord 2009 0.75
69 Two cases of early dystonia of the trunk in Parkinson's disease. J Neurol 2015 0.75
70 Interictal myoclonus with paroxysmal kinesigenic dyskinesia. Mov Disord 2006 0.75
71 Speech disturbances in patients with dystonia or chorea due to neurometabolic disorders. Mov Disord 2010 0.75